Results 111 to 120 of about 341,161 (289)

Boerhaave syndrome in a paediatric patient with diabetic ketoacidosis: A case report [PDF]

Scripta Medica
Diabetic ketoacidosis is a serious and potentially life-threatening complication of type 1 diabetes mellitus (T1DM), which often results from poor glycaemic control.
Alkhalifah Yasir S.
doaj   +1 more source

Pheochromocytoma Masquerading as “Diabetic Ketoacidosis”

, 2016
Diabetic ketoacidosis is a routinely encountered diagnosis in medicine. Physicians are trained early on to look for precipitants. Most clinicians assess for medication compliance, infection, ischemia, and the like.
Maria Nien-Feng Lee MD, Jeffrey Stephen Hedley MD, Rebecca D. Levit MD, Adriana Ioachimescu MD, Sidney Law MD, Sujoy Phookan MD   +5 more
core   +1 more source

Liraglutide and Βeta‐Cell Function in Young Adults With Long‐Standing Type 1 Diabetes and Residual C‐Peptide: A Blinded, Randomized Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate the effect of liraglutide on residual beta‐cell function in adults with long‐standing type 1 diabetes (T1D) and detectable C‐peptide. Materials and Methods In this randomized, blinded, placebo‐controlled trial, 18 adults with T1D duration ≥ 5 years and detectable fasting C‐peptide were assigned to liraglutide or placebo for 52 
José Caballero‐Corbalán, Per Lundkvist, Daniel Espes, Per‐Ola Carlsson   +3 more
wiley   +1 more source

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium‐Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are commonly withheld during hospitalisation because of concerns about diabetic ketoacidosis. We examined whether hospitalisation was associated with discontinuation of SGLT2i and compared patterns with another anti‐hyperglycaemic medicine without similar inpatient safety concerns ...
Tamara Y. Milder, Leah Shepherd, Hans Kristian Raket, Jerry R. Greenfield, Richard O. Day, Jialing Lin, Juliana de Oliveira Costa, Sophie Stocker, Carol A. Pollock, Brendon Neuen, Min Jun, Jane Ludington, Sallie‐Anne Pearson, Michael O. Falster   +13 more
wiley   +1 more source

Diabetic Ketoacidosis: A Review and Update

, 2013
Diabetic ketoacidosis (DKA) remains a significant complication of diabetes in both the United States and around the world. Diabetic ketoacidosis remains a significant complication of diabetes in both the United States and worldwide with its associated ...
Ahmad, Aakif N, DO, Saraceni, Christine, Perilli, Gretchen, MD, Daniels, Michael N, DO   +3 more
core   +1 more source

Community‐Based Personalised Lifestyle Intervention Guided by Intermittent Continuous Glucose Monitoring in Adults With Type 2 Diabetes: A Multicentre Randomised Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims To evaluate whether a community‐based personalised lifestyle intervention guided by intermittent continuous glucose monitoring (CGM) improves glycaemic and cardiometabolic outcomes in adults with type 2 diabetes. Materials and Methods In this multicentre, open‐label randomised trial, 180 adults with type 2 diabetes and pre‐randomisation ...
Yaqing Liu, Shan Zheng, Zifu Yu, Ran Zhao, Qian Li, Suyun Li, Liangxia Chen   +6 more
wiley   +1 more source

Omnipod 5 Delivers Superior Economic Value Compared to Multiple Daily Injections: A Cost‐Effectiveness Analysis in Adults With T1D From a Payer Perspective in Sweden

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Analyse the cost‐effectiveness of the Omnipod 5 automated insulin delivery system versus multiple daily injections (MDI) with continuous glucose monitoring for type 1 diabetes among adults in Sweden. Methods Cost‐effectiveness was analysed with the IQVIA Core Diabetes Model (version 10.0) taking the perspective of the payer in Sweden ...
Johan Jendle, Colin Hopley, Anuj Narang, Raffaele Scarica, Helena Hellerstedt, Melanie Littlewood   +5 more
wiley   +1 more source

The impact of diabetic ketoacidosis and age on behavior six months post-diagnosis in children with type 1 diabetes

, 2010
Objectives: Children with type 1 diabetes mellitus (DM1) may be at increased risk of psychosocial and adjustment difficulties. We examined behavioral outcomes six months post-diagnosis in a group of children with newly diagnosed DM1.\ud \ud Methods: This ...
Wellard, R.M., Scratch, S.E., Nadebaum, C., Northam, E.A., Cameron, F.J., Diabetic Ketoacidocis and Brain Injury Study Group,   +5 more
core   +1 more source

Cardiorenal Mortality and Safety Outcomes of GLP‐1 Receptor Agonists in Type 2 Diabetes With BMI Below 27 kg/m2: A Target Trial Emulation

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Cardiorenal evidence for glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) derives mainly from trials in overweight or obesity; data in adults with Type 2 diabetes (T2D) and body mass index (BMI) below 27 kg/m2 are limited. Materials and Methods We emulated a target trial in the TriNetX US Collaborative Network (index dates 2020 to ...
Shao‐Chia Chen, Yu‐Nan Huang, Pei‐Yun Li, Jo‐Ching Chen, Gideon Meyerowitz‐Katz, Shun‐Fa Yang, Pen‐Hua Su   +6 more
wiley   +1 more source

Cerebral complications in diabetic ketoacidosis [PDF]

, 2005
Although much is known about diabetic ketoacidosis (DKA) and its treatment, the pathology of cerebral complications in patients who develop ketoacidosis is not yet well understood.
Cizmecioglu, FİLİZ MİNE, Toprak, D, Hatun, S   +2 more
core   +1 more source